1,442
Views
33
CrossRef citations to date
0
Altmetric
Original Articles

Prevalence of chronic kidney disease in a Nigerian family practice population

, MBBS, MPH, FMCFM, FWACP, , MBBS, FMCGP, FWACP, FRACGP, , MBBS, FMCP, FWACP & , MBBS, FMCGP
Pages 132-137 | Published online: 15 Aug 2014

References

  • AIHW. Chronic kidney disease in Australia, 2005. Australian Institute of Health and Welfare Cat. No. PHE 68. Canberra: AIHW. Available from http://www.aihw.gov.au (Accessed 27/10/2006).
  • WHO. The World Health Report 2003. Shaping the future. World Health Organization; 2003.
  • Beaglehole R, Yach D. Globalization and the prevention and control of non-communicable disease: the neglected chronic diseases of adults. Lancet 2003; 362: 903–8.
  • National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kid Dis 2002; 39(2 suppl): S1–226.
  • Johnson CA, Levey AS, Coresh J, Levin A, Lau J, Eknoyan G. Clinical practice guidelines for chronic kidney disease in adults. Part I: Definition, disease stages, evaluation, treatment and risk factors. Am Fam Physician 2004; 70: 869–76.
  • Akinsola A, Odesanmi WO, Oguniyi JO, Ladipo GOA. Diseases causing chronic renal failure in Nigerians—a prospective study of 100 cases. Afr J Med Sci 1989; 18: 131–7.
  • Abioye-Kuteyi EA, Akinsola A, Ezeoma IT. Renal disease: the need for community-based screening in rural Nigeria. Afr J Med Pract 1999; 6(5): 198–201.
  • Nwankwo EA, Nwankwo B, Mubi B. Prevalence of impaired kidney function in hospitalized hypertensive patients in Maiduguri, Nigeria. The Internet Journal of Internal Medicine 2006; 6(1).
  • Kadiri S, Walker O, Salako BL, Akinkugbe O. Blood pressure, hypertension and correlates in urbanized workers in Ibadan, Nigeria: a revisit. J Hum Hypertens 1999;13:23–7.
  • Schena FP: Epidemiology of end-stage renal disease: international comparisons of renal replacement therapy. Kidney Int 2000; 57: 39–45.
  • Pugia MJ. Comparison of urine dipsticks with quantitative methods for microalbuminuria. Eur J Clin Chem Biochem 1997; 35(9): 693–700.
  • Agaba EI, Agaba PA, Wigwe CM. Use and abuse of analgesics in Nigeria: a community survey. Niger J Med 2004; 13(4): 379–82.
  • WHO. Obesity and overweight. Available from www.WHO/obesity/overweight.htm (Accessed 23/05/2006).
  • SPSS for Windows. Release 11.0.0 SPSS Inc Standard Version; 2001.
  • McCellan WM, Knight DF, Karp H, Brown WW. Early detection and treatment of renal disease in hospitalized diabetic and hypertensive patients: important differences between practice and published guidelines. Am J Kidney Dis 1997; 29: 368–75.
  • Kissmeyer L, Kong C, Cohen J, Unwin RJ, Woolfson RJ, Neild GH. Community nephrology: audit of screening for renal insufficiency in a high risk population. Nephrol Dial Transplan 1999; 14: 2150–5.
  • Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41: 1–12.
  • Pusley D. Racial and ethnic disparities in renal disease. Kidney Int 2005; 68: 1364–5.
  • Norris KC, Agodoa LY. Unravelling the racial disparity associated with kidney disease. Kidney Int 2005; 68: 914–24.
  • Brenner BM, Mackenzie HS. Nephron mass as a risk factor for progression of renal disease. Kidney Int 1997; suppl 63: S124–7.
  • Nwankwo EA, Wudiri WW, Akinsola A. Risk factors for development of chronic kidney disease among Nigerians with essential hypertension. J Med Sci 2007;7(1).
  • Bosan IB. Chronic kidney disease in Nigeria: primary care physicians must intervene earlier. Nig Med Pract 2006; 49(1/2): 18–23.
  • Mulder WJ, Hillen HFP. Renal function and renal disease in the elderly. Eur J Int Med 2001; 12: 86–97.
  • Rowe JW, Andres R, Tobin JD, Norris AH, Shock NW. The effect of aging on creatinine clearance in men: a cross sectional and longitudinal study. J Ger 1996; 31: 155–63.
  • Chadban SJ, Briganti EM, Kerr PG, et al. Prevalence of kidney damage in Australian adults: the AusDiab kidney study. J Amer Soc Nephr 2003; 14: S131–8.
  • Nwankwo EA, Ummate I. Environmental lead intoxication and chronic kidney disease: a review. Intern J Nephr 2006; 3(1).
  • Alebiosu CO, Ayodele OE. Increasing prevalence of diabetes as a cause of end stage renal disease in Nigeria. Trop Doct 2004; 35(1): 35–8.
  • Alebiosu CO, Ayodele OE. The global burden of CKD and the way forward. Ethn Dis 2005; 15: 418–23.
  • Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. J Amer Med Assoc 2005; 293: 455–62.
  • Stengel B, Tarver-Carr ME, Powe NR, Eberhardt MS, Brancati FL. Lifestyle factors, obesity and the risk of chronic kidney disease. Epid 2003; 14: 479–487.
  • Vupputuri S, Sandler DP. Lifestyle risk factors and chronic kidney disease. Ann Epid 2003; 13(10): 712–20.
  • Stengel B, Couchoud C, Cenee S, Hemon D. Age, blood pressure and smoking effects on chronic renal failure in primary glomerular nephropathies. Kid Int 2000; 57: 2519–26.
  • Hallan SI, Dahl K, Oien CM. Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. BMJ 2006; 333:1047.